🇺🇸 FDA

Company profile · Sponsor

Context

Context Therapeutics

CNTX · NYSE pharma PHILADELPHIA, PA, USA
Pipeline
8
Drugs
0
Patents
3

Quick answer

Context (CNTX) is a pharma company. headquartered in PHILADELPHIA, PA, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 3 patents to this profile..

Company facts

Ticker CNTX
Exchange NYSE
Company type pharma
Headquarters PHILADELPHIA, PA, USA
SEC CIK 0001842952

Pipeline (8)

Search pipeline →

  1. Elacestrant

    Context

    Breast Cancer

    phase 2 small molecule terminated

    2 trials

  2. Extended-release Onapristone

    Context

    Refractory Endometrial Adenocarcinoma

    phase 2 small molecule active

    1 trial

  3. Onapristone

    Context

    ER-positive Breast Cancer

    phase 2 small molecule terminated

    1 trial

  4. Onapristone ER

    Context

    Granulosa Cell Ovarian Cancer

    phase 2 small molecule completed

    1 trial

  5. CT-202

    Context

    Triple Negative Breast Cancer (TNBC)

    phase 1 small molecule active

    1 trial

  6. CT-95

    Context

    Mesothelin-Expressing Tumors

    phase 1 small molecule active

    1 trial

  7. CTIM-76

    Context

    Platinum-resistant Ovarian Cancer

    phase 1 small molecule active

    1 trial

  8. Letrozole

    Context

    Metastatic Breast Cancer

    phase 1 small molecule terminated

    1 trial

Patents (3)

Search patents →

  1. US 11672762

    Onapristone extended-release compositions and methods

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10786461

    Onapristone extended-release compositions and methods

    Expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10548905

    Amorphous onapristone compositions and methods of making the same

    Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Context?

Context (CNTX) is a pharma company. headquartered in PHILADELPHIA, PA, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 3 patents to this profile..

What pipeline programs does Context sponsor?

We track 8 ClinicalTrials.gov-linked programs for Context, including Elacestrant and 7 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Context company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.